资讯

AGC Biologics Expands Cell Therapy Development Operations to Asia to Serve Growing Market Need
AGC Biologics will commence cell therapy process development and clinical manufacturing services on July 1 at AGC Inc.’s ...
Contract Pharma5 小时
AGC Biologics Expands Cell Therapy Development Operations to Asia
AGC Biologics will commence cell therapy process development and clinical manufacturing services at AGC Inc.’s Yokohama ...
Porton Advanced and EVA Pharma Sign MOU to Expand CAR T-Cell Therapy Access in The Middle ...
Porton Advanced Solutions, a global leading cell and gene therapy CDMO service provider, and EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the ...
AllAfrica on MSN6 小时
Sickle Cell Day - Patients Battle High Cost of Drugs, Access to Treatment
People living with Sickle Cell Disease (SCD) in Nigeria have lamented that the high cost of medication and poor access to comprehensive care are weighing heavily on them and their families.They also ...
Contract Pharma5 小时
GenSight Transfers Upstream Phase of LUMEVOQ Manufacturing Process to Catalent
GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies, has transferred the upstream phase of the manufacturing process for LUMEVOQ, its gene ...
Scientific Research Publishing10 小时
A Rare Presentation of Cavernous Sinus Thrombosis in a Young Female ()
Cohen, E. and Kubinak, N. (2025) A Rare Presentation of Cavernous Sinus Thrombosis in a Young Female. Surgical Science, 16, ...
The Scientist14 小时
Scientists Divided on Mexico’s Genetically Modified Corn Ban
Protecting native maize diversity is one of the key arguments behind Mexico’s constitutional ban on genetically modified corn ...